BLMS — Bloomios Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Bloomios, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 1.32 | 8.49 | 6.08 |
| Cost of Revenue | ||||
| Gross Profit | 0 | 0.402 | 3.78 | 2.23 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 0.456 | 2.23 | 8.56 | 11 |
| Operating Profit | -0.456 | -0.917 | -0.065 | -4.88 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.49 | -1.17 | -2.01 | -13.8 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.49 | -1.17 | -2.01 | -13.8 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.49 | -1.17 | -2.01 | -13.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.49 | -1.17 | -2.01 | -13.8 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.039 | -0.094 | -0.184 | -0.947 |